{"id":10653,"date":"2020-08-31T17:57:58","date_gmt":"2020-08-31T12:27:58","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=10653"},"modified":"2025-05-15T14:59:54","modified_gmt":"2025-05-15T09:29:54","slug":"rosacea-treatment-market","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market","title":{"rendered":"Do We Have A Cure For Rosacea?"},"content":{"rendered":"\n

The current\u00a0 Rosacea Pipeline therapies include FMX103 (Foamix Pharmaceuticals), Epsolay (Sol-Gel Technologies), ACU-D1 (Accuitis), HY01 (Hovione Scientia Limited), AFX4031 (Afecta Pharmaceuticals), AOB103 (AOBiome), and others.<\/em>\u00a0The therapies intend to address the unmet needs in the Rosacea treatment market.<\/em><\/strong><\/p>\n\n\n\n

Awareness about any condition is as important as treating the condition itself. Similar is the case with, Rosacea, a characteristic inflammatory condition affecting the skin especially the face resulting in facial erythema or redness. Around one in 10 people in the world is affected by rosacea.<\/strong><\/p>\n\n\n\n

The condition can be controlled differently; however, there is no standard cure for the disease.\u00a0 The treatment also varies with the subtype of rosacea. The treatment is prescribed according to the dominant features of the disease.\u00a0\u00a0<\/p>\n\n\n\n

The current Rosacea therapeutic landscape<\/a> is divided into four major categories based on the route of administration and the approved usage for the condition. These are topical retinoids<\/strong>, topical antibiotics<\/strong>, oral tetracycline-class antibiotics<\/strong> (TCAs), and oral retinoids. <\/strong>Topical retinoids comprise Tretinoin<\/strong>, Tazarotene<\/strong>, Adapalene, and Clindamycin\/tretinoin, along with several other topical therapies that are used to reduce erythema, papules and pustules, and telangiectasias. Tretinoin is the most commonly used and cost-effective topical retinoid. Topical antibiotics, such as metronidazole (e.g. Metrolotion), clindamycin, erythromycin, azelaic acid (e.g. Fincea), benzoyl peroxide, benzoyl peroxide\/clindamycin, benzoyl peroxide\/erythromycin, sulfacetamide, and sulfacetamide\/sulfur, are directly applied to the skin to kill the pathogens, metronidazole being the most commonly used followed by clindamycin, erythromycin, and azelaic acid. In general, sun avoidance and photoprotection are necessary to manage the condition. Skincare routine, including gentle cleanser and moisturizer, improves the therapeutic value of the antibiotics. However, Topical therapies are given a few months, and Topical corticosteroids are avoided.<\/p>\n\n\n\n

Furthermore, oral drugs are available for the treatment of flushing and erythema. Oral tetracycline (TCA)<\/strong> comprises the use of tetracycline, minocycline, and doxycycline (Oracea). They are the anti-inflammatory agents that do not result in bacterial resistance. Of all the Oral TCAs, tetracycline occupies the major share of the chunk of prescriptions, followed by minocycline and doxycycline. Then there are Oral retinoids<\/strong> that involve isotretinoin (e.g. Accutane). Isotretinoin is an FDA and EMA-approved therapy for the treatment of acne and is available as off-label therapy in the rosacea treatment market. <\/p>\n\n\n\n

Furthermore, it is important to carefully study the condition since its pathophysiology and cause remains a mystery. Rosacea management also involves avoiding triggers such as extreme temperatures, exposure to UV rays, allergic food, or beverage, or specific weather conditions.<\/p>\n\n\n\n

Some of the approved therapies to bring relief from the symptoms of the condition include Rhofade (topical oxymetazoline), Mirvaso (brimonidine) topical gel, Finacea (azelaic acid) Foam, Oracea (doxycycline), Soolantra (ivermectin 1% cream), and MetroGel (metronidazole) gel. Recently, in March 2019, Perrigo, <\/strong>an Irish manufacturer of private label over-the-counter pharmaceuticals, <\/strong>received FDA approval for the generic version of Finacea Foam 15%, which the company acquired through a patent litigation suit with Bayer <\/strong>AG. In similar lines, LEO Pharma<\/strong> acquired Finacea Foam 15% from Bayer AG and then substituted for Bayer AG as the lead plaintiff in the patent litigation suit concerning the product. Besides Perrigo, Glenmark <\/strong>also received FDA-approval for azelaic acid gel, 15%, a generic version of Finacea gel. <\/p>\n\n\n\n

Albeit, Topical medications coupled with anti-inflammatory medications are effective in improving symptoms and providing relief from pimples and pustules; however, the erythema of rosacea remains untended. Moreover, the available over-the-counter drugs may trigger and worsen rosacea if paired up with calcium channel blockers, sildenafil, and some vitamin B-related medications. However, there are drugs in the pipeline<\/a> that are designed to address these unmet needs in the rosacea treatment market. However, educating people about rosacea is imperative and needs attention. The condition remains highly underdiagnosed and is frequently misdiagnosed as acne. Pharma players such as Foamix Pharmaceuticals, Sol-Gel Technologies, Accuitis, Hovione Scientia Limited, Afecta Pharmaceuticals, <\/strong>and AOBiome<\/strong> are developing novel therapies to meet the unmet needs of the rosacea treatment market.\u00a0The current Rosacea Pipeline therapies include FMX103 (Foamix Pharmaceuticals), Epsolay (Sol-Gel Technologies), ACU-D1 (Accuitis), HY01 (Hovione Scientia Limited), AFX4031 (Afecta Pharmaceuticals), AOB103 (AOBiome), and others.<\/p>\n\n\n\n

Without a doubt, Rosacea is a challenging condition. With a lack of proper knowledge, it becomes difficult to provide a proper treatment regimen. However, educating people and making them aware of the condition can help avoid triggers, bundled with medical management of the condition to reduce the redness that comes with rosacea. <\/p>\n","protected":false},"excerpt":{"rendered":"

The current\u00a0 Rosacea Pipeline therapies include FMX103 (Foamix Pharmaceuticals), Epsolay (Sol-Gel Technologies), ACU-D1 (Accuitis), HY01 (Hovione Scientia Limited), AFX4031 (Afecta Pharmaceuticals), AOB103 (AOBiome), and others.\u00a0The therapies intend to address the unmet needs in the Rosacea treatment market. Awareness about any condition is as important as treating the condition itself. Similar is the case with, Rosacea, […]<\/p>\n","protected":false},"author":1,"featured_media":10654,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[18706,18709,18707,18710,18708],"industry":[17225],"therapeutic_areas":[17237],"class_list":["post-10653","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-rosacea","tag-rosacea-cure","tag-rosacea-market","tag-rosacea-market-share","tag-rosacea-treatment","industry-pharmaceutical","therapeutic_areas-dermatology"],"acf":[],"yoast_head":"\nRosacea Treatment Market | Rosacea Pipeline Therapies | DelveInsight<\/title>\n<meta name=\"description\" content=\"The current Rosacea Pipeline therapies address the unmet needs in the Rosacea treatment market such as untended erythema, and no cure.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rosacea Treatment Market | Rosacea Pipeline Therapies | DelveInsight\" \/>\n<meta property=\"og:description\" content=\"The current Rosacea Pipeline therapies address the unmet needs in the Rosacea treatment market such as untended erythema, and no cure.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-31T12:27:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-15T09:29:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/08\/31174931\/Rosacea-Treatment-Market.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rosacea Treatment Market | Rosacea Pipeline Therapies | DelveInsight","description":"The current Rosacea Pipeline therapies address the unmet needs in the Rosacea treatment market such as untended erythema, and no cure.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market","og_locale":"en_US","og_type":"article","og_title":"Rosacea Treatment Market | Rosacea Pipeline Therapies | DelveInsight","og_description":"The current Rosacea Pipeline therapies address the unmet needs in the Rosacea treatment market such as untended erythema, and no cure.","og_url":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2020-08-31T12:27:58+00:00","article_modified_time":"2025-05-15T09:29:54+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/08\/31174931\/Rosacea-Treatment-Market.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market","url":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market","name":"Rosacea Treatment Market | Rosacea Pipeline Therapies | DelveInsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/08\/31174931\/Rosacea-Treatment-Market.jpg","datePublished":"2020-08-31T12:27:58+00:00","dateModified":"2025-05-15T09:29:54+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"The current Rosacea Pipeline therapies address the unmet needs in the Rosacea treatment market such as untended erythema, and no cure.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/rosacea-treatment-market#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/08\/31174931\/Rosacea-Treatment-Market.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/08\/31174931\/Rosacea-Treatment-Market.jpg","width":772,"height":482,"caption":"Rosacea Treatment Market | Rosacea Pipeline Therapies"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/08\/31174931\/Rosacea-Treatment-Market-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Rosacea<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Rosacea cure<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Rosacea market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Rosacea market share<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Rosacea treatment<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Rosacea<\/span>","<span class=\"advgb-post-tax-term\">Rosacea cure<\/span>","<span class=\"advgb-post-tax-term\">Rosacea market<\/span>","<span class=\"advgb-post-tax-term\">Rosacea market share<\/span>","<span class=\"advgb-post-tax-term\">Rosacea treatment<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 6 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Aug 31, 2020","modified":"Updated on May 15, 2025"},"absolute_dates_time":{"created":"Posted on Aug 31, 2020 5:57 pm","modified":"Updated on May 15, 2025 2:59 pm"},"featured_img_caption":"Rosacea Treatment Market | Rosacea Pipeline Therapies","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/10653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=10653"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/10653\/revisions"}],"predecessor-version":[{"id":32171,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/10653\/revisions\/32171"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/10654"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=10653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=10653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=10653"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=10653"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=10653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}